Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in Children

被引:0
作者
Files, Megan A. [1 ]
Gentles, Lauren [2 ]
Kehoe, Leanne [3 ]
Adler, Amanda [3 ]
Lacombe, Kirsten [3 ]
Dickerson, Jane A. [4 ,5 ]
Greninger, Alexander [4 ]
Waghmare, Alpana [6 ,7 ,8 ]
Fairlie, Tarayn [9 ]
Pringle, Kimberly [9 ]
Midgley, Claire M. [9 ]
Hagen, Melissa Briggs [9 ]
Englund, Janet A. [3 ,6 ,8 ]
Seshadri, Chetan [1 ]
机构
[1] Univ Washington, Sch Med, Dept Med, 750 Republican St,Suite E663, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Ctr, Div Basic Sci, Seattle, WA USA
[3] Seattle Childrens Res Inst, Div Pediat Infect Dis, MA 7-234,4800 Sand Point Way NE, Seattle, WA 98105 USA
[4] Univ Washington, Sch Med, Dept Lab Med & Pathol, Seattle, WA USA
[5] Seattle Childrens Hosp, Dept Labs, Seattle, WA USA
[6] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[7] Seattle Childrens Hosp, Ctr Clin & Translat Res, Seattle, WA USA
[8] Univ Washington, Dept Pediat, Seattle, WA USA
[9] Ctr Dis Control & Prevent, Coronavirus & Other Resp Viruses Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
children; COVID-19; SARS-COV-2 nucleocapsid antibody; SARS-COV-2 spike antibody; T-cell immunity to SARS-CoV-2;
D O I
10.1093/infdis/jiae301
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The kinetics and durability of T-cell responses to SARS-CoV-2 in children are not well characterized. We studied a cohort of children aged 6 months to 20 years with COVID-19 in whom peripheral blood mononuclear cells and sera were archived at approximately 1, 6, and 12 months after symptom onset. Methods. We compared antibody responses (n = 85) and T-cell responses (n = 30) to nucleocapsid (N) and spike (S) glycoprotein over time across 4 age strata: 6 months to 5 years and 5-9, 10-14, and 15-20 years. Results. N-specific antibody responses declined over time, becoming undetectable in 26 (81%) of 32 children by approximately 1 year postinfection. Functional breadth of anti-N CD4+ T-cell responses also declined over time and were positively correlated with N-antibody responses (Pearson r = .31, P = .008). CD4+ T-cell responses to S displayed greater functional breadth than N in unvaccinated children and, with neutralization titers, were stable over time and similar across age strata. Functional profiles of CD4+ T-cell responses against S were not significantly modulated by vaccination. Conclusions. Our data reveal durable age-independent T-cell immunity to SARS-CoV-2 structural proteins in children over time following COVID-19 infection as well as S-antibody responses in comparison with declining antibody responses to N.
引用
收藏
页码:889 / 900
页数:12
相关论文
共 50 条
  • [31] Analysis of Cell Immunity for Children Infected with SARS-CoV-2 and Those Vaccinated against SARS-CoV-2 Using T-SPOT®.COVID
    Oishi, Tomohiro
    Yasui, Yuto
    Kato, Atsushi
    Ogita, Satoko
    Eitoku, Takahiro
    Enoki, Hideo
    Nakano, Takashi
    MICROORGANISMS, 2024, 12 (05)
  • [32] Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients
    Garanina, Ekaterina
    Hamza, Shaimaa
    Stott-Marshall, Robert J.
    Martynova, Ekaterina
    Markelova, Maria
    Davidyuk, Yuriy
    Shakirova, Venera
    Kaushal, Neha
    Baranwal, Manoj
    Khaertynova, Ilsiyar M.
    Rizvanov, Albert
    Foster, Toshana L.
    Khaiboullina, Svetlana
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [33] Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
    de Miranda Santos, Isabel Kinney Ferreira
    Costa, Carlos Henrique Nery
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [34] T cell immunity to SARS-CoV-2
    Niessl, Julia
    Sekine, Takuya
    Buggert, Marcus
    SEMINARS IN IMMUNOLOGY, 2021, 55
  • [35] Diversity of immune responses in children highly exposed to SARS-CoV-2
    Ubeda, Maria
    Maza, Maria del Carmen
    Delgado, Pilar
    Horndler, Lydia
    Abia, David
    Garcia-Bermejo, Laura
    Serrano-Villar, Sergio
    Calvo, Cristina
    Bastolla, Ugo
    Sainz, Talia
    Fresno, Manuel
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [36] Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals
    Kim, Hyunsuh
    Seiler, Patrick
    Jones, Jeremy C.
    Ridout, Granger
    Camp, Kristi P.
    Fabrizio, Thomas P.
    Jeevan, Trushar
    Miller, Lance A.
    Throm, Robert E.
    Ferrara, Francesca
    Fredrickson, Richard L.
    Lowe, James F.
    Wang, Leyi
    Odemuyiwa, Solomon O.
    Wan, Xiu-Feng
    Webby, Richard J.
    VACCINES, 2020, 8 (04) : 1 - 15
  • [37] Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
    Roltgen, Katharina
    Boyd, Scott D.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2024, 19 : 69 - 97
  • [38] Evaluation of T-cell subsets in pregnant women infected with SARS-CoV-2
    Kulhan, M.
    Ozdemir, H.
    Bilgi, A.
    Celik, C.
    Demir, N. Aktug
    Dagi, H. Turk
    Ucar, M. G.
    Kulhan, N. G.
    Artac, H.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [39] Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
    Zhou, Runhong
    To, Kelvin Kai-Wang
    Wong, Yik-Chun
    Liu, Li
    Zhou, Biao
    Li, Xin
    Huang, Haode
    Mo, Yufei
    Luk, Tsz-Yat
    Lau, Thomas Tsz-Kan
    Yeung, Pauline
    Chan, Wai-Ming
    Wu, Alan Ka-Lun
    Lung, Kwok-Cheung
    Tsang, Owen Tak-Yin
    Leung, Wai-Shing
    Hung, Ivan Fan-Ngai
    Yuen, Kwok-Yung
    Chen, Zhiwei
    IMMUNITY, 2020, 53 (04) : 864 - +
  • [40] Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico
    Madewell, Zachary J.
    Graff, Nathan E.
    Lopez, Velma K.
    Rodriguez, Dania M.
    Wong, Joshua M.
    Maniatis, Panagiotis
    Medina, Freddy A.
    Munoz, Jorge L.
    Briggs-Hagen, Melissa
    Adams, Laura E.
    Rivera-Amill, Vanessa
    Paz-Bailey, Gabriela
    Major, Chelsea G.
    SCIENTIFIC REPORTS, 2024, 14 (01):